Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Healthcare (Basel, Switzerland)|August 12, 2023
Comparative Evaluation of the Clinical Severity of COVID-19 of Vaccinated and Unvaccinated Patients in Southeastern Romania in the First 6 Months of 2022, during the Omicron WaveCorina Manole, Liliana Baroiu, Aurel Nechita, et al.
Therapeutics and Clinical Risk Management|April 7, 2022
The Role of D-Dimers in the Initial Evaluation of COVID-19Liliana Baroiu, Ana Cristina Lese, Ioana Anca Stefanopol, et al.
Nanomaterials (Basel, Switzerland)|December 23, 2022
Ag-Decorated Iron Oxides-Silica Magnetic Nanocomposites with Antimicrobial and Photocatalytic ActivityViorica Muşat, Lenuța Crintea Căpăţână, Elena-Maria Anghel, et al.
Viruses|April 27, 2026
Clinical and Pathophysiological Considerations Related to the Impact of Bulevirtide, a New Entry Inhibitor, in HBV-HDV InfectionRaisa Eloise Barbu, Mariana Daniela Ignat, Roxana Elena Bogdan Goroftei, et al.
Experimental and Therapeutic Medicine|February 7, 2022
Benefits and adverse events of melatonin use in the elderly (Review)Lucreția Anghel, Liliana Baroiu, Corina Rișcă Popazu, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|March 16, 2021
Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST StudyAnca Trifan, Carol Stanciu, Laura Iliescu, et al.
Experimental and Therapeutic Medicine|May 2, 2022
Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review)Liliana Baroiu, Lucreția Anghel, Alin Laurențiu Tatu, et al.
Experimental and Therapeutic Medicine|January 24, 2022
Orthopaedic manifestations of neurofibromatosis type 1: A case reportFlorentina Năstase, Diana Sabina Radaschin, Elena Niculeț, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 29, 2024
Effectiveness of 8-week Treatment with Glecaprevir/Pibrentasvir in Treatment-naïve or -experienced HCV Patients: Results from an Observational Retrospective Study in Real-life Settings (ODYSSEY)Anca Trifan, Carol Stanciu, Adrian Streinu-Cercel, et al.
Pageof 4